Results 31 to 40 of about 11,145 (294)

Tubercular Dactylitis in a 5-Year Girl: A Case Report on Uncommon Presentation of Skeletal Tuberculosis

open access: yesEuropean Journal of Medical and Health Sciences, 2023
Tuberculosis of the spinal cord, which is known as tubercular spondylitis is the most manifested musculoskeletal TB. Tuberculosis also affects the hip joint, knee joint, wrist, and elbow joint in descending order.
Q. Ullah, M. Quader
semanticscholar   +1 more source

Tubercular dactylitis with discharging sinuses: A very rare presentation of skeletal tuberculosis

open access: yesAnnals of Medical Science and Research, 2023
Skeletal tuberculosis is a common form after pulmonary and lymphnode involvement, but involvement of soft tissues is rarely seen after pediatric population.
Alakes Kumar Kole
doaj   +1 more source

Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study

open access: yesJournal of Clinical Medicine, 2023
Introduction: Enthesitis and dactylitis are difficult-to-treat features of psoriatic arthritis (PsA), leading to disability and affecting quality of life.
A. Lo Gullo   +38 more
semanticscholar   +1 more source

MRI changes in psoriatic dactylitisextent of pathology, relationship to tenderness and correlation with clinical indices [PDF]

open access: yes, 2008
Objectives. To quantify the extent of inflammation in psoriatic dactylitis and to examine the relationship between clinical and magnetic resonance imaging (MRI) data in both tender and non-tender dactylitis. Methods.
Chandramohan, M.   +3 more
core   +1 more source

Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

open access: yesJournal of Rheumatology, 2022
Objective This literature review aimed to identify the most efficacious current interventions for dactylitis and provide up-to-date scientific evidence to support the 2021 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA ...
P. Palominos   +20 more
semanticscholar   +1 more source

Treatment recommendations for psoriatic arthritis [PDF]

open access: yes, 2008
Objective: To develop comprehensive recommendations for the treatment of the various clinical manifestations of psoriatic arthritis (PsA) based on evidence obtained from a systematic review of the literature and from consensus opinion.
Boehncke, Wolf-Henning   +14 more
core   +3 more sources

Dactylitis is an indicator of a more severe phenotype independently associated with greater SJC, CRP, ultrasound synovitis and erosive damage in DMARD-naive early psoriatic arthritis

open access: yesAnnals of the Rheumatic Diseases, 2021
Objective To characterise the impact of dactylitis in disease-modifying antirheumatic drug (DMARD)-naive early psoriatic arthritis (PsA). Methods Patients with early PsA meeting the classification criteria for PsA (CASPAR) were recruited.
S. Dubash   +9 more
semanticscholar   +1 more source

Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study [PDF]

open access: yes, 2013
Objectives: To assess long-term golimumab efficacy/safety in patients with active psoriatic arthritis (PsA).<p></p> Methods Adult PsA patients (≥3 swollen, ≥3 tender joints, active psoriasis) were randomly assigned to ...
Beutler, A.   +10 more
core   +1 more source

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force [PDF]

open access: yes, 2013
Background: Therapeutic targets have been defined for diseases like diabetes, hypertension or rheumatoid arthritis and adhering to them has improved outcomes. Such targets are just emerging for spondyloarthritis (SpA). Objective: To define the treatment
Baraliakos, Xenofon   +31 more
core   +2 more sources

Novel use Of Hydroxyurea in an African Region with Malaria (NOHARM): a trial for children with sickle cell anemia [PDF]

open access: yes, 2017
Hydroxyurea treatment is recommended for children with sickle cell anemia (SCA) living in high-resource malaria-free regions, but its safety and efficacy in malaria-endemic sub-Saharan Africa, where the greatest sickle-cell burden exists, remain unknown.
Hodges, James S.   +8 more
core   +2 more sources

Home - About - Disclaimer - Privacy